Proton pump inhibitor versus histamine-2 receptor antagonist for prevention of bleeding after ESD in patients on low-dose aspirin therapy (PH-BEST study)
Not Applicable
Recruiting
- Conditions
- Patients with gastric adenoma or early gastric cancer receiving low-dose aspirin
- Registration Number
- JPRN-UMIN000011915
- Lead Sponsor
- Osaka City University Graduate School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 260
Inclusion Criteria
Not provided
Exclusion Criteria
1. Patients with allergy for rabeprazole and famotidine 2. Patients taking anticoagulants 3. Patients with active peptic ulcer 4. Patients on dialysis 5. Patients under treatment of atazanavir sulfate 6. Patients who have other malignant neoplasms or serious disease
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method